A Clinical trial to evaluate the effectiveness of Adathodai Nei (Medicated Ghee) in the management of Swasakaasam (Bronchial Asthma)
Phase 3
Completed
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2022/02/040237
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1.Patients with clinical symptoms of Sneezing, Rhinitis, Dyspnea, Cough with or without expectoration, Wheeze, Tightness of chest.
2.Wheezing more than 3 weeks.
3.Night time wheezing more than one day/week.
4.Asthma sometimes interferes with normal daily activities.
5.Patients who are willing to undergo spirometry, radiological investigations and provide blood sample for lab investigations.
Exclusion Criteria
KNOWN CASE OF
1.Having covid-19 (or) past history of covid-19
2.Restrictive Lung diseases
3.Tuberculosis
4.Emphysema
5.Pleural effusion
6.Pneumothorax
7.Cardiac diseases and Renal diseases
8.Sleep Apnea
9.Diabetes mellitus
10.Hypertension
11.Pregnancy
12.Lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome will be assessed by measuring Peak expiratory flow pre and post treatment using peak flow meterTimepoint: 2 MONTHS - SCREENING <br/ ><br>2 MONTHS - PATIENT ENROLLMENT <br/ ><br>2 MONTHS - OUTCOME ASSESSMENT
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing clinical signs and symptoms, laboratory parameters of IgE, AEC, ESR before and after treatment.Timepoint: 2 MONTHS - SCREENING <br/ ><br>2 MONTHS - PATIENT ENROLLMENT <br/ ><br>2 MONTHS - OUTCOME ASSESSMENT